Nexo Therapeutics
Andrew Lamas is a Research Associate at nexo therapeutics since June 2023. Previously, Andrew worked as an Undergraduate Research Assistant at Northeastern University in the Sive lab, focusing on the feeding and maintenance of experimental Zebra fish for neurodevelopmental research. Additionally, Andrew gained experience as a Research Associate at TScan Therapeutics working with HEK and T cells. Before that, Andrew worked as a Meal Delivery Driver at WestMass ElderCare, Inc. Andrew holds a Bachelor of Science in Biology from Northeastern University.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.